Had a maximum 6month gap amongst cessation of prior therapy and
Had a maximum 6month gap in between cessation of prior therapy and commencement of fingolimod. Statistical analyses. Patients have been stratified by prior remedy (natalizumab, IFNb/GA, or none) and RRs…